Subthreshold Nanosecond Laser Treatment of Intermediate AMD without Reticular Pseudodrusen: Real-world Three-year Follow-up Study

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

JL's organisation (Adelaide Health Technology Assessment, University of Adelaide) received payment from Nova-Eye Medical for initial statistical analyses; however further analyses and collaboration on the manuscript was subsequently done independently.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The national ethics committees for New Zealand are, by legislation, the Health and Disability Ethics Committees. The Health and Disability Ethics Committees are, by law, the only ethics committees for Hamilton Eye Clinic (the institution where the Study was carried out). The Health and Disability Ethics Committees Office has waived the need for committee review for this study, as it is observational, uses only de-identified data and has no active human participants. I attach the letter from the Health and Disability Ethics Committees Office that states this.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes